Nature Reviews Cancer is a monthly review journal covering the field of oncology. It was established in 2001. The editor-in-chief is Anna Dart.
The American Association for Cancer Research (AACR) is the world's oldest and largest professional association related to cancer research. Based in Philadelphia, the AACR focuses on all aspects of cancer research, including basic, clinical, and translational research into the etiology, prevention, diagnosis, and treatment of cancer. Founded in 1907 by 11 physicians and scientists, the organization now has more than 52,000 members in 130 countries and territories. The mission of the AACR is to prevent and cure cancer through research, education, communication, collaboration, science policy and advocacy, and funding for cancer research.
The British Journal of Cancer (BJC) is a twice-monthly professional medical journal published by Springer Nature's Nature Research.
Integrative Cancer Therapies is a peer-reviewed medical journal focusing on complementary and alternative and integrative medicine in the care for and treatment of patients with cancer. Therapies like diets and lifestyle modifications, as well as experimental vaccines and chemotherapy are the subject of this journal. It was established in 2002 and is published by SAGE Publications. The editor-in-chief is Keith I. Block.
The Journal of Clinical Oncology is a peer-reviewed medical journal published 3 times a month by the Lippincott Williams & Wilkins. It covers research on all aspects of clinical oncology. The journal was established in 1983 and the editor-in-chief is Jonathan W. Friedberg. JCO's Impact Factor is 45.3 as reported by Clarivate in its 2022 Journal Citation Reports.
Cancer is a biweekly peer-reviewed scientific journal covering oncology. The journal was established in 1948. It is an official journal of the American Cancer Society and is published by Wiley-Blackwell on behalf of the society. The first editor-in-chief was Fred W. Stewart, who held that position until 1961. The current editor-in-chief is Suresh S. Ramalingam, and the previous one was Fadlo R. Khuri. Cancer Cytopathology was published as a section from 1997 until 2008, when it was split into a separate journal.
Cancer Cytopathology is a monthly peer-reviewed scientific journal which covers practice of cytopathology and its related oncology-based disciplines. It is one of three official journals of the American Cancer Society and is published by Wiley-Blackwell on behalf of the society. The current editor-in-chief is William C. Faquin. Cancer Cytopathology was published as a section of Cancer from 1997 until 2008 when it was split into a separate journal.
Clinical Cancer Research is a peer-reviewed medical journal on oncology, including the cellular and molecular characterization, prevention, diagnosis, and therapy of human cancer, medical and hematological oncology, radiation therapy, pediatric oncology, pathology, surgical oncology, and clinical genetics. The applications of the disciplines of pharmacology, immunology, cell biology, and molecular genetics to intervention in human cancer are also included. One of the main interests of Clinical Cancer Research is on clinical trials that evaluate new treatments together with research on pharmacology and molecular alterations or biomarkers that predict response or resistance to treatment. Another priority for Clinical Cancer Research is laboratory and animal studies of new drugs as well as molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease. The journal is published by the American Association for Cancer Research.
Cancer Epidemiology, Biomarkers & Prevention is a peer-reviewed medical journal devoted to research in the field of cancer epidemiology. Topics include descriptive, analytical, biochemical, and molecular epidemiology, the use of biomarkers to study the neoplastic and preneoplastic processes in humans, chemoprevention and other types of prevention trials, and the role of behavioral factors in cancer etiology and prevention. It is published by the American Association for Cancer Research and co-sponsored by the American Society of Preventive Oncology.
The European Journal of Cancer is a peer-reviewed medical journal devoted to cancer research on experimental oncology, clinical oncology, and on cancer epidemiology and prevention. It is the official journal of the European Organisation for Research and Treatment of Cancer (EORTC) and the European Society of Breast Cancer Specialists (EUSOMA). The editor-in-chief is Alexander M. M. Eggermont.
The Journal of the National Cancer Institute (JNCI) is a peer-reviewed medical journal covering research in oncology that was established in August 1940. It is published monthly by Oxford University Press and is edited by Patricia A. Ganz. It was merged with Cancer Treatment Reports in January 1988. JNCI used to be the official journal of the U.S. National Cancer Institute (NCI); however, in 1996, the NCI and JNCI agreed to grow apart. Over the next five years, JNCI became independent of the NCI.
Lung Cancer is a peer-reviewed medical journal published by Elsevier originally published on behalf of the International Association for the Study of Lung Cancer. As of 2015, it is published on behalf of the International Lung Cancer Consortium, the European Thoracic Oncology Platform, and the British Thoracic Oncology Group. It includes original research and review articles of relevance to lung cancer.
The American Journal of Clinical Oncology is a bimonthly, peer-reviewed, scientific, oncology journal, published by Lippincott Williams & Wilkins. The editor in chief is David E. Wazer. The journal was formerly entitled Cancer Clinical Trials.
Current Cancer Drug Targets is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ruiwen Zhang. The journal covers research on contemporary molecular drug targets involved in cancer, including medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry. Current Cancer Drug Targets publishes original research reports, review papers, and rapid communications ("letters").
The Journal of Radiation Research is a bimonthly peer-reviewed scientific journal covering research on radiation and oncology. It was established in 1960 and is published by Oxford University Press. Its editor-in-chief is Kenshi Komatsu.
The Asian Pacific Journal of Cancer Prevention is a biweekly peer-reviewed open access medical journal covering oncology. It was established in 2000 and is published by the Asian Pacific Organization for Cancer Prevention, of which it is the official journal. It is also the official journal of the International Association of Cancer Registries. The editor-in-chief is Alireza Mosavi Jarrahi.
The Journal of Cancer Research and Clinical Oncology is a monthly peer-reviewed medical journal covering oncology. It was established in 1903 under the name Zeitschrift für Krebsforschung, and changed its name to Zeitschrift für Krebsforschung und klinische Onkologie in 1971. The journal obtained its current name in 1979. It is published by Springer Science+Business Media under a hybrid publishing model and the editor-in-chief is Klaus Hoffken.
Pediatric Blood & Cancer is a peer-review online-only medical journal covering pediatric oncology and hematology. It was established in 1975 as Medical and Pediatric Oncology, obtaining its current name in 2004. Starting in January 2014, it stopped publishing its print edition and moved to an exclusively online format. The editor-in-chief is Peter E. Newburger. According to the Journal Citation Reports, the journal has a 2021 impact factor of 3.838, ranking it 30th out of 130 journals in the category "Pediatrics", 39th out of 78 journals in the category "Hematology", and 141st out of 245 journals in the category "Oncology".
Veterinary and Comparative Oncology is a quarterly peer-reviewed scientific journal covering new scientific developments in veterinary oncology and comparative oncology. It was established in 2003 and is published by John Wiley & Sons on behalf of the Veterinary Cancer Society.
Nature Cancer is a monthly peer-reviewed academic journal published by Nature Portfolio. It was established in 2020. The editor-in-chief is Alexia-Ileana Zaromytidou.
